MCRB
Seres Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.95
+8.94%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.08x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.57x
- Price / sales
- 10.40x
- Price / cash flow
- -0.38x
Enterprise value
- Enterprise value
- $60.6M
- EV / sales
- 32.20x
- EV / EBITDA
- -1.35x
- EV / EBIT
- -0.72x
- Market cap
- $19.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026